Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

All of the 25(OH)D variants used in previous MR analyses were successfully replicated, with comparable SNP-25(OH)D effect sizes (see Supplementary Table 1).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis reported · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization

Source: Article title.

The UK Biobank cohort (UKB) comprises close to half a million participants aged between 37 and 70 years from across the United Kingdom.

Source: Methods.

For keratinocyte cancers (KC), we performed separate fixed effect inverse-variance-weighted squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) meta-analysis of GWAS summary data available in Liyanage and colleagues, derived from 23andMe, Inc., a personal genetics company, and the QSkin cohort.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization

Genetic instrumental-variable study · Nature Communications · 2021

Original publication title

A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization

Jue-Sheng Ong; Suzanne C. Dixon-Suen; Xikun Han; Jiyuan An; Esophageal Cancer ConsortiumFitzgeraldRebecca21BuasMatt22GammonMarilie D.23CorleyDouglas A.24ShaheenNicholas J.25HardieLaura J.26BirdNigel C.27ReidBrian J.28ChowWong-Ho29RischHarvey A.30YeWeimin31LiuGeoffrey32RomeroYvonne33BernsteinLeslie34WuAnna H.35WhitemanDavid E.VaughanThomas36; 23 and Me Research TeamAgeeM.37AlipanahiB.37AutonA.37BellR. K.37BrycK.37ElsonS. L.37FontanillasP.37FurlotteN. A.37HindsD. A.37HuberK. E.37KleinmanA.37LittermanN. K.37McIntyreM. H.37MountainJ. L.37NoblinE. S.37NorthoverC. A. M.37PittsS. J.37SathirapongsasutiJ. Fah37SazonovaO. V.37SheltonJ. F.37ShringarpureS.37TianC.37TungJ. Y.37VacicV.37WilsonC. H.37; Upekha Liyanage; Jean-Cluade Dusingize; Johannes Schumacher; Ines Gockel; Anne Böhmer; Janusz Jankowski; Claire Palles; Tracy O’Mara; Amanda Spurdle; Matthew H. Law; Mark M. Iles; Paul Pharoah; Andrew Berchuck; Wei Zheng; Aaron P. Thrift; Catherine Olsen; Rachel E. Neale; Puya Gharahkhani; Penelope M. Webb; Stuart MacGregor

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Previous Mendelian randomization (MR) studies on 25-hydroxyvitamin D (25(OH)D) and cancer have typically adopted a handful of variants and found no relationship between 25(OH)D and cancer; however, issues of horizontal pleiotropy cannot be reliably addressed. Using a larger set of variants associated with 25(OH)D (74 SNPs, up from 6 previously), we perform a unified MR analysis to re-evaluate the relationship between 25(OH)D and ten cancers. Our findings are broadly consistent with previous MR studies indicating no relationship, apart from ovarian cancers (OR 0.89; 95% C.I: 0.82 to 0.96 per 1 SD change in 25(OH)D concentration) and basal cell carcinoma (OR 1.16; 95% C.I.: 1.04 to 1.28).

However, after adjustment for pigmentation related variables in a multivariable MR framework, the BCC findings were attenuated. Here we report that lower 25(OH)D is unlikely to be a causal risk factor for most cancers, with our study providing more precise confidence intervals than previously possible.

Studies of the genetic association between vitamin D and cancer risk have typically been underpowered. Here the authors analyse this using Mendelian Randomisation with more than 70 vitamin D variants obtained from the UK Biobank and large-scale data from various consortia, confirming null associations between vitamin D and most cancers.

Authors’ abstract

Previous Mendelian randomization (MR) studies on 25-hydroxyvitamin D (25(OH)D) and cancer have typically adopted a handful of variants and found no relationship between 25(OH)D and cancer; however, issues of horizontal pleiotropy cannot be reliably addressed. Using a larger set of variants associated with 25(OH)D (74 SNPs, up from 6 previously), we perform a unified MR analysis to re-evaluate the relationship between 25(OH)D and ten cancers. Our findings are broadly consistent with previous MR studies indicating no relationship, apart from ovarian cancers (OR 0.89; 95% C.I: 0.82 to 0.96 per 1 SD change in 25(OH)D concentration) and basal cell carcinoma (OR 1.16; 95% C.I.: 1.04 to 1.28).

However, after adjustment for pigmentation related variables in a multivariable MR framework, the BCC findings were attenuated. Here we report that lower 25(OH)D is unlikely to be a causal risk factor for most cancers, with our study providing more precise confidence intervals than previously possible.

Studies of the genetic association between vitamin D and cancer risk have typically been underpowered. Here the authors analyse this using Mendelian Randomisation with more than 70 vitamin D variants obtained from the UK Biobank and large-scale data from various consortia, confirming null associations between vitamin D and most cancers.

Publication and source details

Original title: A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization

Jue-Sheng Ong; Suzanne C. Dixon-Suen; Xikun Han; Jiyuan An; Esophageal Cancer ConsortiumFitzgeraldRebecca21BuasMatt22GammonMarilie D.23CorleyDouglas A.24ShaheenNicholas J.25HardieLaura J.26BirdNigel C.27ReidBrian J.28ChowWong-Ho29RischHarvey A.30YeWeimin31LiuGeoffrey32RomeroYvonne33BernsteinLeslie34WuAnna H.35WhitemanDavid E.VaughanThomas36; 23 and Me Research TeamAgeeM.37AlipanahiB.37AutonA.37BellR. K.37BrycK.37ElsonS. L.37FontanillasP.37FurlotteN. A.37HindsD. A.37HuberK. E.37KleinmanA.37LittermanN. K.37McIntyreM. H.37MountainJ. L.37NoblinE. S.37NorthoverC. A. M.37PittsS. J.37SathirapongsasutiJ. Fah37SazonovaO. V.37SheltonJ. F.37ShringarpureS.37TianC.37TungJ. Y.37VacicV.37WilsonC. H.37; Upekha Liyanage; Jean-Cluade Dusingize; Johannes Schumacher; Ines Gockel; Anne Böhmer; Janusz Jankowski; Claire Palles; Tracy O’Mara; Amanda Spurdle; Matthew H. Law; Mark M. Iles; Paul Pharoah; Andrew Berchuck; Wei Zheng; Aaron P. Thrift; Catherine Olsen; Rachel E. Neale; Puya Gharahkhani; Penelope M. Webb; Stuart MacGregor

Nature Communications · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T14:42:30.395198+00:00

DOI: 10.1038/s41467-020-20368-w · PMC7801600